Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

(2017) et al.   JAMA Oncology

MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response

(2016) Vincent Ho et al.   PLoS One

Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy

(2015) L.J. Forker et al.   CLINICAL ONCOLOGY

Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas

(2015) Mo-Jin Wang et al.   MEDICINE

The radiosensitivity index predicts for overall survival in glioblastoma

(2015) Kamran A. Ahmed et al.   Oncotarget

Efficacy of Surgery and Adjuvant Therapy in Older Patients With Colorectal Cancer

(2015) Lie Yang et al.   MEDICINE

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

(2014) A. J. Breugom et al.   ANNALS OF ONCOLOGY

The Mre11/Rad50/Nbs1 complex: Recent insights into catalytic activities and ATP-driven conformational changes

(2014) Tanya T. Paull et al.   EXPERIMENTAL CELL RESEARCH

The MRE11 complex: An important source of stress relief

(2014) Katrin Rein et al.   EXPERIMENTAL CELL RESEARCH

MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial

(2014) Thomas Pavelitz et al.   PLoS One

Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials

(2013) Nuh N. Rahbari et al.   ANNALS OF SURGICAL ONCOLOGY

Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells

(2013) Lisa A. McPherson et al.   CANCER LETTERS

The Different Roles of hRAD50 in Microsatellite Stable and Unstable Colorectal Cancers

(2013) Jingfang Gao et al.   DISEASE MARKERS

The modern anatomical surgical approach to localised rectal cancer

(2013) R.G. Orsini et al.   EJC SUPPLEMENTS

Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention

(2013) Dora Colussi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Differences in Survival between Colon and Rectal Cancer from SEER Data

(2013) Yen-Chien Lee et al.   PLoS One

Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

(2012) Rolf Sauer et al.   JOURNAL OF CLINICAL ONCOLOGY

MRE11 Deficiency Increases Sensitivity to Poly(ADP-ribose) Polymerase Inhibition in Microsatellite Unstable Colorectal Cancers

(2011) E. Vilar et al.   CANCER RESEARCH

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

(2010) A. Choudhury et al.   CANCER RESEARCH

Microsatellite instability in colorectal cancer—the stable evidence

(2010) Eduardo Vilar et al.   Nature Reviews Clinical Oncology

Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11

(2008) R. Rodriguez et al.   CLINICAL CANCER RESEARCH

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene

(2008) Jirina Bartkova et al.   Molecular Oncology